GLO1 and diabetic kidney disease: In patients with a long duration of diabetes (≥50 years) without the development of DKD, GLO1 protein was significantly increased compared to both age-matched non-diabetic controls without kidney disease and T2D patients (patients with diabetes mellitus type 2) who had developed DKD (CKD3/4) [142].